Skip to main content

D. E. Shaw & Co., Inc.

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1009207 New York, NY

Position in APLS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
186,853
-58.4% QoQ
Ownership
0.146%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 93% Shared 0% None 7%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Derivatives in APLS

reported options exposure · as of Dec 31, 2025
CallValue
$0
CallShares
13,900
PutValue
$0
PutShares
15,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
37 filing rows on record
Report Date Value (USD) Shares
2026-03-31 186,853
2025-12-31 15,000
2025-12-31 449,676
2025-12-31 13,900
2025-09-30 456,791
2025-09-30 13,900
2025-09-30 15,000
2025-06-30 22,700
2025-06-30 251,069
2025-06-30 13,900
2025-03-31 38,100
2025-03-31 18,200
2024-12-31 31,000
2024-12-31 20,000
2024-12-31 31,700
2024-09-30 31,700
2024-06-30 34,900
2024-03-31 37,700
2023-12-31 33,086
2023-12-31 29,500
2023-09-30 39,473
2023-09-30 29,500
2023-06-30 527,811
2023-06-30 29,500
2023-03-31 412,853
2022-12-31 12,898
2022-09-30 197,364
2022-06-30 4,570
2022-03-31 33,034
2021-12-31 37,890
2021-09-30 75,522
2021-06-30 245,029
2021-03-31 336,643
2020-12-31 414,062
2020-09-30 385,866
2020-06-30 531,761
2020-03-31 369,733